Surgical management of the cases with both biliary and duodenal obstruction
- Author:
Yoshihiro MIYASAKA
1
;
Takao OHTSUKA
;
Vittoria Vanessa VELASQUEZ
;
Yasuhisa MORI
;
Kohei NAKATA
;
Masafumi NAKAMURA
Author Information
- Publication Type:Review
- Keywords: Cholestasis; Duodenal obstruction; Surgical procedures, operative
- MeSH: Cholestasis; Constriction, Pathologic; Duodenal Obstruction; Gastric Bypass; Gastric Emptying; Humans; Length of Stay; Mortality; Pain, Postoperative; Recurrence; Surgical Procedures, Operative
- From:Gastrointestinal Intervention 2018;7(2):74-77
- CountryRepublic of Korea
- Language:English
- Abstract: Endoscopic management is presently the recommended first-line of treatment for biliary strictures. However, surgery still has an important role especially for biliary obstruction (BO) with duodenal obstruction. Even though endoscopic treatment for concurrent BO and gastric-outlet obstruction has been proposed, it is still not widespread. Duodenal obstruction is often associated with malignant BO which makes endoscopic treatment more challenging. Biliary and gastrointestinal double bypass with Roux-en-Y hepaticojejunostomy and gastrojejunostomy is the most common surgical intervention for malignant biliary and gastric-outlet obstruction. A variety of procedures of biliary bypass and gastrointestinal bypass have been reported. According to several studies, mortality rates range from 0% to 7%, while morbidity rates range from 3% to 50%. Higher morbidity was observed in symptomatic patients caused by the disease. Most common morbidity after double bypass was delayed gastric emptying. Recurrence of BO and gastric-outlet obstruction was less frequently seen after surgical bypass compared to after endoscopic treatment. Minimally invasive approach has been applied to double bypass. Studies showed that laparoscopic double bypass has a shorter hospital stay and reduced postoperative pain; however, due to its technical demand, it is still presently an uncommon procedure. Robotic bypass surgery may resolve this issue in the future. Further analyses of outcomes of both surgical and endoscopic treatments are necessary to establish better and suitable palliation options for concurrent biliary and duodenal obstruction caused by unresectable malignant tumors.
